|

BMS-986165 Clinical Trials

2 actively recruiting trials across 2 locations

No change since May 2026

Pipeline

Phase 2: 1Phase 4: 1

Top Sponsors

  • Memorial Sloan Kettering Cancer Center1
  • Bristol-Myers Squibb1

Indications

  • Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)1
  • Systemic Lupus Erythematosus (SLE)1
  • Lupus1
  • Prostate Cancer1
  • Cancer1

Farmington, Connecticut1 trial

A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132

Local Institution - 0001

Phase 4

Basking Ridge, New Jersey1 trial

A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.